At Genprex, we are dedicated to transforming the lives of patients battling cancer and diabetes through pioneering gene therapies. Our innovative approaches focus on reintroducing tumor suppressor genes to combat cancer and stabilizing glucose levels in diabetes. With multiple FDA Fast Track Designations and promising clinical trial results, Genprex is at the forefront of medical advancements, striving to bring hope and improved outcomes to patients worldwide.
Learn more about our novel gene therapies for cancer and diabetes.
Learn more about the novel gene therapies we are developing for cancer and diabetes.
We’re passionate about the work we’re doing to revolutionize the fight against cancer and diabetes. Whether you or somebody you know is afflicted by one of these diseases, you are a medical practitioner interested in our treatment options, or you are an investor that has supported our fight, we want to keep you informed of our advancements. For up-to-the-minute company news delivered straight to your inbox, sign up for our email newsletter.
